Abstract:Insulin and glucagon regulate the expression and/or activity of a variety of proteins to maintain blood glucose within normal limits. A key target is the gene encoding phosphoenolpyruvate carboxykinase (PEPCK), which catalyzes the first committed step in hepatic gluconeogenesis. Acute regulation of PEPCK is achieved by modulating transcription of the gene, which is tightly regulated by cAMP (the mediator of glucagon and catecholamines), glucocorticoids and insulin. Normally, PEPCK expression is induced by glucagon, catecholamines and glucocorticoids during periods of fasting and in response to stress, but is dominantly inhibited by glucose-induced increases in insulin secretion upon feeding. The incomplete effectiveness of insulin action, whether due to intermittent insulin injection in type I diabetics or insulin resistance in type II diabetics, contributes to hyperglycemia and complications, resulting in damage to the eyes, nerves, kidneys and other organs over time. Thus, defining a molecular mechanism for insulin inhibition of PEPCK gene transcription has been a major goal of research in several labs, because it would allow the development of drugs to prevent episodic increases in circulating glucose in diabetics. Here, we review the main lines of investigation into this complex problem and the likely properties of an inhibitor. Any mechanism must account for the rapidity, specificity and dominance with which insulin is known to act in regulating PEPCK transcription. To date Foxo1 (FKHR) is the only transcription factor for which a complete path from the insulin receptor to gene regulation has been described. While this explains the regulation of some genes, such as IGFBP-1, Foxo1 appears not to play a requisite role in regulating PEPCK transcription. Investigation of cis-acting elements in the PEPCK promoter has shed considerable light on the mechanisms of activation by cAMP and glucocorticoids but has failed to identify a regulatory element that mediates insulin inhibition of transcription. This, together with evidence from analysis of the inducing mechanisms, has prompted us, and others, to investigate the possibility that insulin disrupts activation rather than independently promoting repression. Thus, we hypothesize that insulin-induced modification of a key transcription regulatory protein prevents an essential factor from participating in the induction process, leading to rapid but reversible inhibition, as is seen in animals. The ability to alter the sensitivity of a key transcription factor to improve insulin-regulated control of blood glucose would be a major improvement in the treatment of diabetes, a growing problem in the industrialized world.

Regulation of the PEPCK Promoter Activity Induced by Insulin,Dexamethasone and Glucagon in Vitro

Insulin Regulation of PEPCK Gene Expression: A Model for Rapid and Reversible Modulation

Insulin Regulates the Expression of the Enhancer of Split- and Hairy-Related Protein-2 Gene Via Different Pathways in 3T3-L1 Adipocytes and L6 Myotubes

PGC-1α Coactivates Human PEPCK Gene Transcription

Role of Peroxisome Proliferator-Activated Receptor Gamma in Glucose-Induced Insulin Secretion

Insulin Promotes the Expression of the Gluconeogenic Rate-Limiting Enzymes Phosphoenolpyruvate Carboxykinase (pepck) and Glucose 6-Phosphatase (g6pase) Through PI3k/Akt/mTOR Signaling Pathway in Goose Hepatocytes

Factors That Control the Tissue-Specific Transcription of the Gene for Phosphoenolpyruvate Carboxykinase-C

Insulin Stimulates Pancreatic-Duodenal Homoeobox Factor-1 (pdx1) Dna-Binding Activity and Insulin Promoter Activity in Pancreatic Beta Cells

Analysis of A Novel Dexamethasone Response Element and A Putative C/Ebps Cis-Motif: Controlling Pai-1 Gene Expression During Adipocyte Differentiation

Prostaglandin E 2 Regulates Foxo Activity Via the Akt Pathway: Implications for Pancreatic Islet Beta Cell Dysfunction

Stimulation of Endothelin-1 Gene Expression by Insulin Via Phosphoinositide-3 Kinase–glycogen Synthase Kinase-3Β Signaling in Endothelial Cells

CCAAT/enhancer Binding Protein-Beta Negatively Regulates the Expression of Glycerol-3-phosphate Dehydrogenase 1 in Pig PK-15 Cells.

PREB Regulates Transcription of Pancreatic Glucokinase in Response to Glucose and Camp

Transcriptional Regulation of Pyruvate Dehydrogenase Kinase

Regulation of Glucose-6-Phosphatase Gene Expression by Insulin and Metformin

LINC MIR503HG Controls SC‐β Cell Differentiation and Insulin Production by Targeting CDH1 and HES1

A small-molecule inducer of PDX1 expression identified by high-throughput screening

Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo.

Insulin, Dexamethasone and Methylisobutylxanthine Regulate PAI-1 Gene Expression in 3T3-L1 Adipocytes

Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1‐driven gluconeogenesis

PDX1 and ISL1 Differentially Coordinate with Epigenetic Modifications to Regulate Insulin Gene Expression in Varied Glucose Concentrations.